You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,105,324


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,105,324 protect, and when does it expire?

Patent 10,105,324 protects OBREDON and is included in one NDA.

Summary for Patent: 10,105,324
Title:Immediate release oral guaifenesin solution
Abstract: Disclosed is a method of treating or ameliorating a condition which can be treated or ameliorated by the administration of guaifenesin, which method comprises orally administering to a subject in need thereof an effective amount of an immediate release solution for oral administration of guaifenesin and at least one additional drug. In addition to water the solution comprises as solvents propylene glycol and glycerol in a concentration which significantly increases the bioavailability of guaifenesin in the human body.
Inventor(s): Hafey; Paul (Keller, TX)
Assignee: SOVEREIGN PHARMACEUTICALS, LLC (Fort Worth, TX)
Application Number:15/796,938
Patent Claim Types:
see list of patent claims
Use; Formulation; Dosage form;
Patent landscape, scope, and claims:

United States Patent 10,105,324: A Detailed Analysis of Scope and Claims

Introduction

The United States Patent 10,105,324, titled "Immediate Release Oral Guaifenesin Solution," is a significant patent in the pharmaceutical sector, particularly in the realm of respiratory health. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Background

Guaifenesin is a commonly used expectorant in over-the-counter (OTC) medications, helping to thin and loosen mucus, making it easier to cough up. The patent in question focuses on an immediate release oral solution of guaifenesin, which is designed to provide rapid relief from respiratory symptoms.

Patent Scope

Claim Structure

The patent scope is defined by the claims, which are the legal boundaries of what the patent protects. For US Patent 10,105,324, the claims are structured to cover the composition, method of preparation, and the therapeutic use of the immediate release oral guaifenesin solution.

  • Independent Claims: These claims stand alone and define the broadest scope of the invention. They typically include the essential features of the invention without referencing other claims.
  • Dependent Claims: These claims build upon the independent claims and add additional limitations, narrowing the scope but providing further specificity and protection[3].

Claim Language and Clarity

The clarity and breadth of patent claims are crucial for determining patent scope. The claims in US Patent 10,105,324 are written to be clear and specific, avoiding overly broad language that could lead to disputes over patent validity. The use of precise terminology ensures that the scope of the patent is well-defined and understandable[3].

Key Claims

Composition Claims

The patent includes claims related to the composition of the immediate release oral guaifenesin solution. These claims specify the concentration of guaifenesin, the type of solvents used, and other excipients that enhance the stability and efficacy of the solution.

Method of Preparation Claims

Claims also cover the method of preparing the solution, including the steps involved in mixing the ingredients, the conditions under which the solution is formulated, and any specific processing requirements.

Therapeutic Use Claims

The patent claims also extend to the therapeutic use of the solution, specifying the indications for which the solution is intended, such as the relief of cough and congestion.

Patent Landscape

Related Patents

The patent landscape for guaifenesin formulations is extensive, with numerous patents covering various aspects such as extended-release formulations, combination therapies, and different delivery systems. For example, other patents might focus on sustained-release formulations or guaifenesin combined with other active ingredients like dextromethorphan or pseudoephedrine[5].

Competitors and Market Impact

The immediate release oral guaifenesin solution patent positions its holder competitively in the market by offering a rapid and effective solution for respiratory symptoms. Competitors may have similar products, but the specific formulation and method of preparation protected by this patent provide a unique selling point.

Examination Process and Patent Quality

The examination process for US Patent 10,105,324 would have involved a thorough review by the United States Patent and Trademark Office (USPTO) to ensure that the claims are novel, non-obvious, and meet the requirements for patentability. The process tends to narrow the scope of patent claims, ensuring that the granted patent is of high quality and does not overly broaden the scope of protection[3].

Statistics and Trends

  • Patent Maintenance Payments: The maintenance payments for this patent would be indicative of its value and the ongoing interest in the technology. Higher maintenance payments often correlate with narrower, more specific claims that are less likely to be challenged[3].
  • Forward Citations: The number of forward citations, or the number of times this patent is cited by subsequent patents, can indicate its influence and importance in the field.

Expert Insights

Industry experts often emphasize the importance of clear and specific claims in pharmaceutical patents. For instance, "Software patents in particular have been criticized for having unduly broad and/or unclear claims employing functional claiming language," which highlights the need for precision in claim drafting to avoid legal disputes[3].

Illustrative Statistics

  • Claim Length and Count: Studies have shown that narrower claims at publication are associated with a higher probability of grant and a shorter examination process. For US Patent 10,105,324, the claim length and count would be analyzed to determine how they align with these trends[3].

Key Takeaways

  • Clear and Specific Claims: The patent's claims are structured to be clear and specific, avoiding broad language that could lead to disputes.
  • Comprehensive Coverage: The patent covers the composition, method of preparation, and therapeutic use of the immediate release oral guaifenesin solution.
  • Competitive Advantage: The unique formulation and method of preparation provide a competitive edge in the market.
  • High-Quality Patent: The patent has undergone a thorough examination process to ensure it meets the requirements for patentability.

FAQs

What is the main focus of US Patent 10,105,324?

The main focus of US Patent 10,105,324 is an immediate release oral guaifenesin solution, designed to provide rapid relief from respiratory symptoms.

How are the claims structured in this patent?

The claims are structured to include independent claims that define the broadest scope of the invention and dependent claims that add additional limitations for further specificity.

What is the significance of claim clarity in pharmaceutical patents?

Claim clarity is crucial to avoid disputes over patent validity and to ensure that the scope of the patent is well-defined and understandable.

How does the examination process impact patent scope?

The examination process tends to narrow the scope of patent claims, ensuring that the granted patent is of high quality and does not overly broaden the scope of protection.

What are some key statistics that indicate the value of this patent?

Key statistics include patent maintenance payments and forward citations, which can indicate the value and influence of the patent in the field.

How does this patent position its holder in the market?

The patent positions its holder competitively by offering a unique and effective solution for respiratory symptoms, providing a rapid and immediate release formulation of guaifenesin.

Sources

  1. US Patent Full-Text and Image Database: For additional details on the patents granted.
  2. Google Patents: Interface for a virtual digital assistant, US10241752B2.
  3. Hoover Institution: Patent Claims and Patent Scope.
  4. Google Patents: Methods and apparatuses for automatic speech recognition, US10283110B2.
  5. PubChem: Immediate release oral guaifenesin solution, US-10105324-B2.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,105,324

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sovereign Pharms OBREDON guaifenesin; hydrocodone bitartrate SOLUTION;ORAL 205474-001 Nov 14, 2014 DISCN Yes No 10,105,324 ⤷  Subscribe Y Y A METHOD OF INCREASING THE BIOAVAILABILITY OF GUAIFENESIN IN A SOLUTION CONTAINING 54% TO 66% BY WEIGHT OF PROPYLENE GLYCOL AND GLYCEROL, WHEREIN THE METHOD INCREASES THE CMAX BY AT LEAST 1.5 AND/OR INCREASES THE AUC (0-INF) BY AT LEAST 1.4 ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.